Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
3,076,248
-
Share change
-
+2,374,454
-
Total reported value
-
$32,019,000
-
Price per share
-
$10.41
-
Number of holders
-
21
-
Value change
-
+$24,720,607
-
Number of buys
-
18
-
Number of sells
-
6
Institutional Holders of TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP) as of Q1 2014
As of 31 Mar 2014 TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP) had 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,076,248 shares of stock of the company.
Largest 10 holders included FRANKLIN RESOURCES INC, Broadfin Capital, LLC, BLUESTEIN R H & CO, KINGDON CAPITAL MANAGEMENT, L.L.C., SABBY MANAGEMENT, LLC, DEERFIELD MANAGEMENT CO, Lombard Odier Asset Management (USA) Corp, WALL STREET ASSOCIATES, VANGUARD GROUP INC, and BOGLE INVESTMENT MANAGEMENT L P /DE/.
This table shows 21 institutional shareholders of the security as of 31 Mar 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.